Skip to content
Vimta Labs logo

Vimta Labs

VIMTALABS NSE
₹497.85 No trade today
P/E
27.89
View as Markdown
MCP
Close 4 Nov 2026 ₹497.85 −124.05 −19.9% 1Y
Start ₹621.90

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
25.20%
Debt to Equity
0.01
EPS (TTM)
₹17.85
Book Value
₹109.92
Market Cap
—
P/E (TTM)
27.89
P/B
4.53
ROE
18.90%
Dividend Yield
0.41%
EBITDA
₹90.80 Cr
52W High
₹675.00
52W Low
₹376.05
Volume
0

Peer Comparison

Healthcare › Healthcare Technology › Healthcare Research, Analytics & Technology

Vimta Labs peer comparison
Syngene International
₹417.5076.05₹16,536 Cr3.470.31%7.78%9.99%₹3,600 Cr₹221 Cr
Indegene
₹617.1037.04₹14,947 Cr4.430.37%14.40%18.80%₹3,813 Cr₹401 Cr
Suven Life Sciences
₹276.10—₹7,549 Cr11.390.00%−81.50%−79.50%₹9 Cr−₹353 Cr
Vimta Labs (this company)
₹497.8527.89₹2,195 Cr4.530.41%18.90%25.20%₹419 Cr₹80 Cr
Fabtech Technologies
₹132.309.94₹589 Cr1.340.46%12.50%13.60%₹418 Cr₹49 Cr
Take
₹11.4213.13₹161 Cr5.440.00%16.50%18.50%₹85 Cr₹13 Cr
Median 6 companies₹346.8027.89₹4,872 Cr4.480.34%13.45%16.05%₹419 Cr₹64 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

62 Good

Data confidence 100/100

Category scores

Quality
69
Strong
Returns, margins, earnings quality 22% weight
Valuation
58
Good
Cheap vs sector & own history 24% weight
Growth
50
Average
Sales & profit trajectory 9% weight
Financial Health
90
Strong
Solvency, leverage, coverage 9% weight
Momentum
31
Poor
Trend strength, vol-adjusted 12% weight
Ownership
71
Strong
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 30.0% CAGR over last 5 years

No weaknesses listed

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1153
OscillatorsNeutral252
Moving AveragesStrong Bearish901

Key readings

RSI (14)
39.87
Neutral
MACD (12,26,9)
−24.02
Bullish
SMA (50)
574.36
Bearish
SMA (200)
523.44
Bearish

As of

Analyst Rating

Based on 1 analysts
BUY100%

1 of 1 analyst rates Buy, 0 Hold, 0 Sell.

As of

BUY
1
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+11.42%
5Y+14.26%
3Y+8.92%
1Y+18.31%
TTM+14.17%

Net profit

Net profit growth by window
10Y+29.24%
5Y+30.01%
3Y+18.39%
1Y+16.42%
TTM+8.11%

Operating cash flow

Operating cash flow growth by window
10YTurned positive
5Y+31.77%
3Y+19.11%
1Y+56.38%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+21.12 pp
5Y+9.53 pp
3Y+5.05 pp
1Y−0.58 pp
TTM−1.05 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹154 Cr
Mar 2018₹183 Cr
Mar 2019₹213 Cr
Mar 2020₹181 Cr
Mar 2021₹209 Cr
Mar 2022₹276 Cr
Mar 2023₹315 Cr
Mar 2024₹289 Cr
Mar 2025₹344 Cr
Mar 2026₹407 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹11.00 Cr
Mar 2018₹16.00 Cr
Mar 2019₹25.00 Cr
Mar 2020₹7.00 Cr
Mar 2021₹21.00 Cr
Mar 2022₹41.00 Cr
Mar 2023₹47.00 Cr
Mar 2024₹41.00 Cr
Mar 2025₹67.00 Cr
Mar 2026₹78.00 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹163 Cr +8.3% vs FY26
Reported High Mean Low

Quarterly Results

₹ Cr
VIMTALABS quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
82
64
73
73
75
85
90
94
98
102
99
109
109
112
Expenses
58
48
50
47
49
55
57
61
64
68
64
70
72
74
Operating Profit
24
17
23
26
26
30
33
33
34
34
34
39
37
38
OPM %
29%
26%
31%
36%
35%
35%
37%
35%
35%
34%
35%
36%
34%
34%
Other Income
1
0
0.89
0.49
−1
−1
5
2
2
3
0
3
4
3
Interest
0
1
1
1
0
0
1
0
0
0
0
0
0
0
Depreciation
8
9
8.64
8
8
8
10
9
10
10
11
13
13
13
PBT
16
8
13
16
17
20
28
25
25
26
23
29
28
28
Tax %
25%
25%
25%
24%
26%
24%
23%
27%
25%
24%
25%
27%
26%
25%
Net Profit
12
6
9
12
12
15
22
18
19
20
18
21
21
21
EPS (₹)
2.63
1.34
2.14
2.79
2.77
3.44
4.84
4.12
4.24
4.47
3.94
4.73
4.71
—

Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
VIMTALABS profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
116
138
154
183
213
181
209
276
315
289
344
407
419
Expenses
99
119
127
138
155
151
156
196
222
195
222
266
274
Operating Profit
17
19
27
45
58
30
53
80
94
94
122
142
145
OPM %
15%
14%
18%
25%
27%
17%
25%
29%
30%
33%
35%
35%
35%
Other Income
1
1
1
1
2
3
1
0
3
−4
4.24
8.99
9
Interest
1
1
2
5
5
4
2
2
3
2
2
1
1
Depreciation
11
10
10
16
20
21
23
23
31
33
35
44
46
PBT
7
8
17
26
35
8
28
55
64
55
89
104
107
Tax %
24%
23%
36%
36%
28%
17%
25%
26%
26%
25%
25%
25%
—
Net Profit
5
6
11
16
25
7
21
41
47
41
67
78
80
EPS (₹)
1.14
1.45
2.4
3.72
5.73
1.57
4.81
9.29
10.68
9.26
15.13
17.35
17.85
Div. Payout %
44%
34%
0%
27%
17%
0%
21%
11%
9%
11%
7%
12%
—

Balance Sheet

₹ Cr
VIMTALABS balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
4
4
4
4
4
4
4
4
4
4
9
Reserves
118
122
132
148
167
169
190
229
276
310
374
448
Borrowings
4
26
44
40
26
32
30
19
15
19
9
3
Other Liabilities
21
23
42
40
40
39
49
54
65
61
79
102
Total Liabilities
146
176
222
232
237
245
273
306
360
394
467
562
Fixed Assets
88
88
88
140
135
131
128
162
168
166
230
305
CWIP
0
6
53
0
4
2
17
0
12
59
38
18
Investments
0
0
0
0
0
6
6
6
6
0
0
2
Other Assets
58
82
80
92
99
105
122
138
174
170
198
237
Total Assets
146
176
222
232
237
245
273
306
360
394
467
562

Cash Flow

₹ Cr
VIMTALABS cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
15
−1
24
33
39
24
37
59
87
61
94
147
Investing
−8
−16
−39
−24
−16
−20
−32
−38
−57
−76
−76
−130
Financing
−9
19
13
−8
−23
−1
−5
−16
−11
−2
−16
−10
Net Cash Flow
−1
2
−2
1
1
3
1
5
19
−17
2
7
Free Cash Flow
8
−17
−16
9
23
10
5
20
37
−14
17
47
CFO/OP
96
4
107
86
85
101
84
94
106
81
95
121

Ratios

VIMTALABS financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82
100
101
111
100
117
128
102
93
110
113
95
Inventory Days
158
213
183
209
199
191
140
154
195
260
210
203
Days Payable
66
77
184
148
115
114
139
108
124
87
88
79
Cash Conversion Cycle
174
236
100
172
184
194
128
147
164
283
235
219
Working Capital Days
109
99
22
62
78
64
89
87
78
98
96
83
ROCE %
6%
7%
11%
17%
21%
6%
14%
24%
24%
20%
25%
25%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vimta Labs insights

67 extracted metrics across FY06–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 35.64%
  • Others 34.00%
  • Public 24.80%
  • FIIs 5.07%
  • DIIs 0.48%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Vimta Labs

What does Vimta Labs Ltd do?
Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider
Where is Vimta Labs Ltd (VIMTALABS) listed?
Vimta Labs Ltd trades as VIMTALABS on the NSE and under code 524394 on the BSE.
Which sector does Vimta Labs Ltd belong to?
Vimta Labs Ltd is classified under the Healthcare sector, in the Healthcare Technology industry.
What is the PE ratio of Vimta Labs Ltd?
Vimta Labs Ltd trades at a PE ratio of 27.89 as of 4 Nov 2026, on earnings per share of ₹17.85, against a book value of ₹109.92 per share.
What is the 52-week high and low of Vimta Labs Ltd?
Over the last 52 weeks Vimta Labs Ltd has traded between ₹376.05 and ₹675 as of 4 Nov 2026.
Does Vimta Labs Ltd pay dividends?
Vimta Labs Ltd has a dividend yield of 0.41%.
What is the Return on Equity (ROE) of Vimta Labs Ltd?
Vimta Labs Ltd reported a return on equity of 18.90%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider

Website vimta.com
CEO Dr. Sivalinga Prasad Vasireddi
Employees 1,315
Listed 15 Dec 2005
Face Value ₹2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VIMTALABS.md for Vimta Labs Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month